✦ LIBER ✦

PND25 ECONOMIC EVALUATION OF NATALIZUMAB IN THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN 4 EUROPEAN COUNTRIES

✍ Scribed by C Brennig; E Walter; V Schöllbauer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND23 Economic Evaluation of Natalizumab

✍ S.T. Alexopoulos; B. Deniz; A.R. Walker; R. Arnold; D. Bates 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PND32 Economic Evaluation of Natalizumab

✍ Reyes, A.; Sánchez-Mejorada, G.; Trejo, W. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PND14 Budgetary Impact of the Treatment

✍ García-Ruiz, A.J.; Izquierdo Ayuso, G.; Garcia-Agua Soler, N. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Natalizumab is effective as second line

✍ N. Putzki; K. Kollia; S. Woods; E. Igwe; H. C. Diener; V. Limmroth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PND9 THE COST-EFFECTIVENESS OF NATALIZUM

✍ K Meyer; E Chiao 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PND33 Cost Minimization Analysis of Fing

✍ B. Verheggen; M. Treur; M. Groot 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB